Interagency Autism Coordinating Committee (IACC)
Autism Research Database (AFD)
| Project Element | Element Description |
|---|---|
Project TitleProject Title |
PsychoGenics Inc. |
Principal InvestigatorPrincipal Investigator |
No PI Listed |
DescriptionDescription |
SFARI is partnering with Roche Pharmaceuticals and the contract research organization PsychoGenics to characterize a prioritized set of mouse models using standard assays and PsychoGenics’ CubeTM Technology. The models that will studied include lines modeling the multigenic copy number deletion of the orthologue of the human 16p11.2 interval, different Shank3 mutations, the CNTNAP2 deletion and, going forward, the line model carrying a mutation in PTEN and the mouse model of Timothy Syndrome (CACNA1C). This project emphasizes automated data collection and analyses that are anticipated to yield an unbiased and comprehensive dataset spanning multiple developmental time-points and domains of functions (e.g., social, cognitive, neurological). |
FunderFunder |
Simons Foundation |
Funding CountryFunding Country |
United States |
Fiscal Year FundingFiscal Year Funding |
0 |
Current Award PeriodCurrent Award Period |
2016 |
Strategic Plan QuestionStrategic Plan Question |
Question 2: What is the Biology Underlying ASD? |
Funder’s Project LinkFunder’s Project Link |
No URL available. |
InstitutionInstitution |
PsychoGenics Inc. |
Institute LocationInstitute Location |
United States |
Project NumberProject Number |
|
Government or PrivateGovernment or Private |
Private |
History/Related ProjectsHistory/Related Projects |
PsychoGenics Inc. |
147925
| 2012 |
N/A
|
